Antineoplastic potential of curcumin (cooperative study in Bulgaria and Germany)

Abe Y, Hashimoto S, Horie T (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41–47 Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59 Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30(2):85–94 Aggarwal BB, Sethi G, Ahn KS et al (2006a) Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091:151–169 Aggarwal S, Ichikawa H, Takada Y et al (2006b) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69(1):195–206 Alaikov T, Konstantinov SM, Tzanova T et al (2007) Antineoplastic and anticlastogenic properties of curcumin. Ann N Y Acad Sci 1095:355–370 Anand P, Kunnumakkara AB, Newman RA et al (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818 Anand P, Thomas SG, Kunnumakkara AB et al (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76(11):1590–1611 Aoki H, Takada Y, Kondo S et al (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72(1):29–39 Balasubramanian S, Eckert RL (2007) Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apoptosis in human epidermal keratinocytes. J Biol Chem 282(9):6707–6715 Barik A, Mishra B, Shen L et al (2005) Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic Biol Med 39(6):811–822 Barik A, Mishra B, Kunwar A et al (2007) Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur J Med Chem 42(4):431–439 Bharti AC, Donato N, Aggarwal BB (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171(7):3863–3871 Bharti AC, Shishodia S, Reuben JM et al (2004a) Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103(8):3175–3184 Bharti AC, Takada Y, Aggarwal BB (2004b) Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172(10):5940–5947 Bhattacharyya S, Mandal D, Saha B et al (2007) Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem 282(22):15954–15964 Burg G, Kempf W, Cozzio A et al (2005) WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32(10):647–674 Cao J, Jia L, Zhou H-M et al (2006) Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci 91(2):476–483 Chakravarti N, Myers JN, Aggarwal BB (2006) Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 119(6):1268–1275 Chen W-F, Deng S-L, Zhou B et al (2006) Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups. Free Radic Biol Med 40(3):526–535 Cho JW, Lee KS, Kim C (2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19(3):469–474 Criscione VD, Weinstock MA (2007) Incidence of cutaneous T-cell lymphoma in the United States, 1973–2002. Arch Dermatol 143(7):854–859 Dhandapani KM, Mahesh VB, Brann DW (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102(2):522–538 Duvoix A, Blasius R, Delhalle S et al (2005) Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223(2):181–190 Fang J, Lu J, Holmgren A (2005) Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280(26):25284–25290 Gaedeke J, Noble NA, Border WA (2005) Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney Int 68(5):2042–2049 Ghoneim AI (2009) Effects of curcumin on ethanol-induced hepatocyte necrosis and apoptosis: implication of lipid peroxidation and cytochrome c. Naunyn Schmiedebergs Arch Pharmacol 379(1):47–60 Goel A, Aggarwal BB (2010) Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62(7):919–930 Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75(4):787–809 Gradisar H, Keber MM, Pristovsek P et al (2007) MD-2 as the target of curcumin in the inhibition of response to LPS. J Leukoc Biol 82(4):968–974 Guenova ML, Michova A, Balatzenko GN et al (2012) A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia—a possible new therapeutic target. Hematology 17(3):132–139 Gupta SC, Kim JH, Prasad S et al (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29(3):405–434 Gupta SC, Kim JH, Kannappan R et al (2011a) Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med 236(6):658–671 Gupta SC, Prasad S, Kim JH et al (2011b) Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 28(12):1937–1955 Gupta SC, Patchva S, Koh W et al (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39(3):283–299 Hatcher H, Planalp R, Cho J et al (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65(11):1631–1652 Huang TS, Lee SC, Lin JK (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88(12):5292–5296 Jagetia GC, Aggarwal BB (2007) “Spicing up” of the immune system by curcumin. J Clin Immunol 27(1):19–35 Jain S, Zain J, O’Connor O (2012) Novel therapeutic agents for cutaneous T-Cell lymphoma. J Hematol Oncol 5:24 Javvadi P, Segan AT, Tuttle SW et al (2008) The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73(5):1491–1501 Jefremov V, Zilmer M, Zilmer K et al (2007) Antioxidative effects of plant polyphenols: from protection of G protein signaling to prevention of age-related pathologies. Ann N Y Acad Sci 1095:449–457 Joe B, Lokesh BR (1994) Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224(2):255–263 Kapur S, Tiemann M, Menke MA et al (2005) The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases. Indian J Med Res 121(1):46–54 Khafif A, Hurst R, Kyker K et al (2005) Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132(2):317–321 Kim YH, Liu HL, Mraz-Gernhard S et al (2003) Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 139(7):857–866 Kim SJ, Son TG, Park HR et al (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283(21):14497–14505 Kobayashi T, Hashimoto S, Horie T (1997) Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54(7):819–824 Koiram PR, Veerapur VP, Kunwar A et al (2007) Effect of curcumin and curcumin copper complex (1:1) on radiation-induced changes of anti-oxidant enzymes levels in the livers of Swiss albino mice. J Radiat Res 48(3):241–245 Konstantinov SM, Kostovski A, Berger MR (2002) Will human urinary bladder carcinoma respond to treatment with alkylphosphocholines and curcumin? Facta Univ Ser Med Biol 9(1):111–113 Krejsgaard T, Vetter-Kauczok CS, Woetmann A et al (2006) Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 20(10):1759–1766 Kunnumakkara AB, Guha S, Krishnan S et al (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67(8):3853–3861 Kunwar A, Kunwar A, Narang H et al (2007) Delayed activation of PKCdelta and NFkappaB and higher radioprotection in splenic lymphocytes by copper (II)-Curcumin (1) complex as compared to curcumin. J Cell Biochem 102(5):1214–1224 Kunwar A, Barik A, Mishra B et al (2008) Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta 1780(4):673–679 Kurup VP, Barrios CS (2008) Immunomodulatory effects of curcumin in allergy. Mol Nutr Food Res 52(9):1031–1039 Lamprecht B, Kreher S, Mobs M et al (2012) The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome. Br J Dermatol 167(2):240–246 Landis-Piwowar KR, Milacic V, Chen D et al (2006) The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resist Updat 9(6):263–273 Lev-Ari S, Starr A, Vexler A et al (2006a) Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 26(6B):4423–4430 Lev-Ari S, Strier L, Kazanov D et al (2006b) Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford) 45(2):171–177 Li M, Zhang Z, Hill DL et al (2007) Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67(5):1988–1996 Li JY, Horwitz S, Moskowitz A et al (2012) Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag Res 4:75–89 Ligeret H, Barthelemy S, Zini R et al (2004) Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore. Free Radic Biol Med 36(7):919–929 Liontas A, Yeger H (2004) Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24(2B):987–998 McNally SJ, Harrison EM, Ross JA et al (2007) Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19(1):165–172 Meghana K, Sanjeev G, Ramesh B (2007) Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 577(1–3):183–191 Mitra A, Chakrabarti J, Banerji A et al (2006) Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol 25(4):679–690 Mukhopadhyay A, Basu N, Ghatak N et al (1982) Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12(4):508–515 Padhye S, Banerjee S, Chavan D et al (2009) Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice. Pharm Res 26(11):2438–2445 Park C, Moon D-O, Choi I-W et al (2007) Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 20(3):365–372 Park J, Ayyappan V, Bae E-K et al (2008) Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol 2(4):317–326 Patel BB, Sengupta R, Qazi S et al (2008) Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122(2):267–273 Priyadarsini KI, Maity DK, Naik GH et al (2003) Role of phenolic O–H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med 35(5):475–484 Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11(3):495–510 Reddy AC, Lokesh BR (1992) Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem 111(1–2):117–124 Selvam C, Jachak SM, Thilagavathi R et al (2005) Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg Med Chem Lett 15(7):1793–1797 Shishodia S, Amin HM, Lai R et al (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70(5):700–713 Shishodia S, Singh T, Chaturvedi MM (2007) Modulation of transcription factors by curcumin. Adv Exp Med Biol 595:127–148 Song G, Mao YB, Cai QF et al (2005) Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38(12):1791–1798 Stanchev S, Pencheva I, Konstantinov S et al (2012) Application of UV–V is spectrophotometric and chemiluminescent methods for the evaluation of the antioxidant action of curcumin. J Serb Chem Soc 77(8):1063–1069 Sung B, Kunnumakkara AB, Sethi G et al (2009) Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther 8(4):959–970 Suzuki M, Nakamura T, Iyoki S et al (2005) Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull 28(8):1438–1443 Syng-Ai C, Kumari AL, Khar A (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3(9):1101–1108 Tourkina E, Gooz P, Oates JC et al (2004) Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31(1):28–35 Tsvetkov P, Asher G, Reiss V et al (2005) Inhibition of NAD(P)H: quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA 102(15):5535–5540 Wan XH, Li YW, Luo XP (2007) Curcumin attenuated the lipid peroxidation and apoptotic liver injury in copper-overloaded rats. Zhonghua Er Ke Za Zhi 45(8):604–608 Wong HK, Mishra A, Hake T et al (2011) Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br J Haematol 155(2):150–166 Wu J, Wood GS (2011) Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma. Arch Dermatol 147(4):443–449 Xiao H, Xiao Q, Zhang K et al (2010) Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R. Ann Hematol 89(4):399–404 Yosifov DY, Todorov PT, Zaharieva MM et al (2011) Erucylphospho-N, N, N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity. Cancer Chemother Pharmacol 67(1):13–25 Yosifov DY, Kaloyanov KA, Guenova ML et al (2014) Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines. Leuk Res 38(1):49–56 Zhang C, Li B, Zhang X et al (2010) Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients’ PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol 130(8):2110–2119 Zsila F, Bikádi Z, Simonyi M (2004) Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human alpha1-acid glycoprotein. Bioorg Med Chem 12(12):3239–3245